Pharmacoeconomic Review Report for Nusinsersin; Appendix 1, Cost Comparison. Nusinersen (Spinraza): (Biogen Canada Inc.): Indication: Treatment of patients with 5q SMA. CADTH Common Drug Review
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.